Open AccessGanciclovir use evaluation in kidney transplantation departments
Author(s) -
Maryam Mozaffar,
Shahrzad Shahidi,
Shirinsadat Badri
Publication year - 2016
Publication title -
journal of research in pharmacy practice
Language(s) - Uncategorized
Resource type - Journals
eISSN - 2319-9644
pISSN - 2279-042X
DOI - 10.4103/2279-042x.185742
Subject(s) - medicine , ganciclovir , contraindication , discontinuation , guideline , transplantation , kidney transplantation , azathioprine , drug , adverse effect , intensive care medicine , surgery , pharmacology , human cytomegalovirus , alternative medicine , disease , immunology , virus , pathology
In this study, we evaluated certain aspects of the usage and administration of one lifesaving, high-cost medication, i.e., Ganciclovir for the prevention and treatment of cytomegalovirus (CMV) infection in transplant patients.